NCT07093255View on ClinicalTrials.gov

Safety, PK and PD of FLQ-101 in Premature Neonates

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Retinopathy of Prematurity (ROP)

Interventions

DRUG

FLQ-101

"The invervention comprises 3 Groups:~* Group 1: Low Dose~* Group 2: Middle Dose~* Group 3: High Dose"

All Listed Sponsors

lead

FELIQS INC.

INDUSTRY